Skip to main content
logo
Beam Therapeutics Inc. (BEAM)
NASDAQ: BEAM · Real-Time Price · USD
23.10
-0.12 (-0.52%)
At close: Sep 16, 2026, 4:00 PM EDT
23.28
+0.18 (0.78%)
After-hours: Sep 16, 2026, 4:10 PM EDT

Beam Therapeutics Revenue

Beam Therapeutics had revenue of $490.00K in the quarter ending June 30, 2026, a decrease of -94.21%. This brings the company's revenue in the last twelve months to $156.04M, up 158.88% year-over-year. In the year 2025, Beam Therapeutics had annual revenue of $139.74M with 120.01% growth.

Revenue (ttm)
$156.04M
Revenue Growth
+158.88%
P/S Ratio
14.92
Revenue / Employee
$288,954
Employees
540
Market Cap
2.31B

Revenue Chart

Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025139.74M76.23M120.01%
Dec 31, 202463.52M-314.19M-83.18%
Dec 31, 2023377.71M316.79M520.01%
Dec 31, 202260.92M9.08M17.51%
Dec 31, 202151.84M51.82M215,916.67%
Dec 31, 202024.00K6.00K33.33%
Dec 31, 201918.00K--
Dec 31, 2018---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Sarepta Therapeutics1.97B
Harmony Biosciences Holdings959.90M
Aurinia Pharmaceuticals311.51M
Precigen85.72M
Viridian Therapeutics71.13M
Nektar Therapeutics54.59M
Ocular Therapeutix52.06M
Revenue Rankings

BEAM News

More News